Helmholtz Institute Würzburg

What Helmholtz Institute Würzburg does

The Helmholtz Institute Würzburg (HIRI), legally the Helmholtz Institute for RNA-based Infection Research, is a public non-profit research institute founded in May 2017 in Würzburg, Germany, operating as a site of the Helmholtz-Zentrum für Infektionsforschung GmbH (HZI) in cooperation with Julius-Maximilians-Universität Würzburg (JMU). The institute concentrates on RNA biology in bacterial and viral infection, combining molecular infection biology with technologies including Single-Cell Analysis, Dual RNA-seq, differential RNA-seq, CRISPR-based tools, RAP-MS, CLIP-seq, Ribo-seq, and transposon mutagenesis. It is structured around 5 active research groups with 6 additional associated and alumni group leaders, and operates the Single-Cell Center Würzburg together with the Infection Atlas interactive data platform.

HIRI's revenue model is non-commercial: it receives annual core funding from the federal government of Germany and the Free State of Bavaria, with approximately 30% of its budget derived from competitive third-party grants, including 7 European Research Council grants. It does not sell products or charge for research services; dissemination occurs through peer-reviewed publications, the Würzburg Life Science Seminar Series, and structured graduate training programs ('RNA & Infection' and 'RNAmed - Future Leaders in RNA-based Medicine'). Technology transfer to industry partners and academic collaborators is the primary commercial interface, alongside co-development research.

The institute is expanding physical capacity with a new building on the Medical Campus Würzburg (Bavaria- and EU-funded, completion planned for 2027) and is investing in computational RNA analysis methods. Its primary stakeholders are the academic research community, graduate trainees, and public funders; the institute's strategic significance for PE/VC audiences lies in its role as a pipeline for RNA-therapeutics and CRISPR-tooling IP, talent, and translational opportunities, rather than as a directly investable commercial entity.

Name

Helmholtz Institute Würzburg

Legal name

Helmholtz Institute for RNA-based Infection Research (HIRI)

Website

https://helmholtz-hiri.de

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Helmholtz Institute Würzburg is a public non-profit research institute specializing in RNA-based infection biology, operating within the Helmholtz Association under HZI. It runs 5 research groups, the Single-Cell Center Würzburg, and graduate training programs, funded by German federal, Bavarian, and European Research Council grants.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)

akta.pro primary industry

RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics) (HLAAADAG)

akta.pro secondary industries

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), mRNA Therapeutics (vaccines, protein replacement, immuno-oncology) (HLAAADAA)

Keywords

• RNA infection research
• Single-cell analysis
• Host-pathogen biology
• CRISPR technologies
• Biomedical research institute

Headquarters

HQ city

Würzburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Government Core Funding: Sound annual core funding from federal government and Free State of Bavaria as a public research institution within the Helmholtz Association
2. Third Party Funding: Competitive research grants including ERC Grants (7 grants secured). Third party funding rate of 30% supporting specific research projects and collaborations

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Helmholtz Institute Würzburg (HIRI) is a public research institute that conducts fundamental and applied research on RNA biology in bacterial and viral infections. It operates research groups, graduate training programs ('RNA & Infection' and 'RNAmed'), and the Single-Cell Center Würzburg with its Infection Atlas platform, using technologies such as Dual RNA-seq, differential RNA-seq, CLIP-seq, RAP-MS, and CRISPR-based methods to advance RNA-based diagnostics and therapeutics.

Product overview

The Helmholtz Institute Würzburg (HIRI) is a research institute focused on RNA-based infection research, not a commercial product company. The institute conducts fundamental research using cutting-edge technologies including single-cell analysis, RNA sequencing, and CRISPR tools to understand host-pathogen interactions. HIRI offers graduate training programs ('RNA & Infection' and 'RNAmed') and operates the Single-Cell Center Würzburg, which provides research services and maintains the Infection Atlas platform. The institute's research groups work on various aspects of RNA biology including bacterial infections, viral evolution, and CRISPR technologies, with the goal of advancing RNA-based therapeutics and diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

• Single-Cell Center Würzburg: A specialized center focused on single-cell analysis technologies and infection biology research.
• Graduate Program 'RNA & Infection'
• Graduate Program 'RNAmed - Future Leaders in RNA-based Medicine'

Products and services

• Single-Cell Center Würzburg A research service center providing single-cell analysis technologies and infrastructure for infection biology research, including the Infection Atlas platform for data visualization and sharing.
• Graduate Program 'RNA & Infection' Graduate training program focused on RNA biology and infection research, providing PhD-level training for researchers in the field.
• Graduate Program 'RNAmed - Future Leaders in RNA-based Medicine' Advanced graduate program training future leaders in RNA-based medicine research and development, with a focus on therapeutic applications.

Quantifiable outcome

• 7 ERC Grants secured by institute researchers
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Helmholtz Centre for Infection Research (HZI)coreStrategic or Co-development Partner · 1 May 2017HZI is the parent organization of HIRI. The institute is a site of the Braunschweig Helmholtz Centre for Infection Research, providing core institutional support and funding.
• Julius-Maximilians-Universität Würzburg (JMU)coreStrategic or Co-development Partner · 1 May 2017HIRI operates in close cooperation with JMU Würzburg. Prof. Jörg Vogel holds positions at both HIRI (as Director) and JMU's Institute for Molecular Infection Medicine.

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Broad Institute of MIT and Harvard: Major US biomedical research institute with significant RNA biology, infectious disease, and CRISPR programs. Comparable in research scope and methodology (RNA-seq, single-cell analysis) but much larger scale.
• Wellcome Sanger Institute: UK-based genomics and infectious disease research institute with strong pathogen genomics and RNA biology programs. Comparable research scope including Lars Barquist's prior affiliation.
• Francis Crick Institute: Major UK biomedical discovery institute with infection biology and RNA research programs. Comparable as a large public research institute with similar funding structure and research breadth.
• Pasteur Institute: Leading French infectious disease research institute with extensive RNA biology and microbiology programs. Comparable as a major European public research center focused on infection biology.
• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences with strong RNA biology and infection research programs. Comparable as a publicly funded European research institution with cutting-edge technology platforms.

Direct peers

• Max Planck Institute for Infection Biology: Berlin-based Max Planck institute conducting molecular infection biology research. Highly comparable as a German public research institute focused on understanding infectious disease mechanisms at the molecular level.
• Helmholtz Centre for Infection Research (HZI): HZI is HIRI's parent organization and a major German infection biology research center. Both organizations focus on infection biology research within the Helmholtz Association, with HZI operating as the broader parent site in Braunschweig.
• Twincore - Centre for Experimental and Clinical Infection Research: Joint facility between HZI and Hannover Medical School focused on infection research. Directly comparable as a German infection biology research institute with similar funding and scope.
• Institute of Molecular Infection Biology (IMIB), University of Würzburg: JMU Würzburg institute led by Prof. Vogel in his dual role. Directly comparable given shared leadership, overlapping research themes (RNA-based infection biology), and physical co-location.

Emerging players

• Whitehead Institute for Biomedical Research: MIT-affiliated research institute with strong RNA biology and CRISPR programs. Comparable in size and research scope, particularly in mechanistic studies of RNA processes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/helmholtz_hiri
• YouTubeyoutube.com/channel/UCx_RL4iFxN_SzQVbKJ4nY0A
• LinkedInlinkedin.com/company/helmholtz-hiri
• Instagraminstagram.com/helmholtz_hiri

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Helmholtz Institute Würzburg